USE OF INTERLEUKIN 6 ANTAGONISTS FOR THE TREATMENT OF DISEASES CHARACTERISED BY HIGH LEVELS OF AROMATASE.

摘要

The invention described herein relates to the use of human interleukin 6 antagonists, totally incapable of binding to gp 130, as specific inhibitors of the enzyme aromatase, useful for the treatment of hormone dependent tumours, and particularly tumours of the breast.